AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound legal payout.
Week ahead: Shell, Next and a heap of blue chip earnings proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
FTSE 100
Bernstein raises Diageo price target to 3,600 pence -.
Oxford Biomedica plc (LON:OXB – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 207.89 ($2.61) and traded as low as GBX 197 ($2.47). Oxford Biomedica shares last traded at GBX 203 ($2.55), with a volume of 115,462 shares traded. […]
Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike Bonney as Chairman of the.